Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

Xiuiu Yang, Shanwei Ye, Qian Xu, Jue Wang, Caroline Markmann, Lingfeng Zhang, Shujia Zhang, Xinyue Deng, Jiali Cheng, Jia Wu, Vijay Bhoj, Zheng Zhang, Liang Huang

Blood (2024) 144 (Supplement 1): 89.

https://doi.org/10.1182/blood-2024-210125

Published: 2024

Journal Articles

A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma

Fengyan Jin, MD PhD, Guangxun Gao, MD, Yujun Dong, MD, Chunrui Li, MD PhD, Wenrong Huang, Limo Zhang, MD, Qiang Zhu, MD, Ruifeng Yuan, MD, Li Xu, MD, Yanjie Xu, MD, Qian Xu, Shaji K. Kumar, MD, Yun Dai, MD

Blood (2019) 134 (Supplement_1): 3094.

https://doi.org/10.1182/blood-2019-132076

Published: 2019

Journal Articles

Droplet Digital PCR Monitoring of TP53 Mutated Circulating Tumor DNA Levels in Lymphoma Patients

Xiaolu Long, Jia Gu, Yaoyao Lou, Qian Xu, Haodong Cai, MD, Wei Zhang, MD, Kefeng Shen, Min Xiao, MD PhD, Yicheng Zhang, MD PhD, Liting Chen, PhD, Jianfeng Zhou, PhD

Blood (2018) 132 (Supplement 1): 4106.

https://doi.org/10.1182/blood-2018-99-113825

Published: 2018

Journal Articles

Targeting Burkitt Lymphoma By CAR-Extracellular Vesicles: A Tropism-Delivery Platform for CRISPR/Cas9 System

Qian Xu, Zheng Zhang, MD, Lei Zhao, MD, Yun Qin, Yicheng Zhang, MD PhD, Jue Wang, MD PhD, Jianfeng Zhou, MD PhD

Blood (2018) 132 (Supplement 1): 3487.

https://doi.org/10.1182/blood-2018-99-115003

Published: 2018

Journal Articles

Cell-Based Immunotherapy with Different Subsets of Tolerogenic Dendritic Cell in Idiopathic Thrombocytopenic Purpura.

Xiao-Lin Zhang, PhD, Jun Peng, MD, Shu-Qian Xu, Xin-Guang Liu, Yuan Yu, MD, Ping Qin, MD, Yan Shi, PhD, Lin Wang, PhD, Ming Hou, MD, PhD

Blood (2008) 112 (11): 3408.

https://doi.org/10.1182/blood.V112.11.3408.3408

Published: 2008

NARROW

Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma

Droplet Digital PCR Monitoring of TP53 Mutated Circulating Tumor DNA Levels in Lymphoma Patients

Targeting Burkitt Lymphoma By CAR-Extracellular Vesicles: A Tropism-Delivery Platform for CRISPR/Cas9 System

Cell-Based Immunotherapy with Different Subsets of Tolerogenic Dendritic Cell in Idiopathic Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

Targeted-Delivery Strategy of Engineered EV Functionalized By Anti-CD3/CD19 Bi-Specific T-Cell Engager in Treating B-Cell Malignancies

A Multi-Center Epidemiological and Prognostic Analysis of Cytogenetic Abnormalities in a Cohort of 1015 Chinese Patients with Newly-Diagnosed Multiple Myeloma

Droplet Digital PCR Monitoring of TP53 Mutated Circulating Tumor DNA Levels in Lymphoma Patients

Targeting Burkitt Lymphoma By CAR-Extracellular Vesicles: A Tropism-Delivery Platform for CRISPR/Cas9 System

Cell-Based Immunotherapy with Different Subsets of Tolerogenic Dendritic Cell in Idiopathic Thrombocytopenic Purpura.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only